ArticleThe International journal on drug policy2022
COVID-19 and the opportunity for gender-responsive virtual and remote substance use treatment and harm reduction services.
Article in The International journal on drug policy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 42 citations in OpenAlex.
- Trial
- Access to health and harm reduction services during drug decriminalization in British Columbia, Canada: a mixed-method study.BMC public health · 2026Article
- Policy recommendations for overdose response hotlines and applications as a harm reduction tool: A commentary.Canadian journal of public health = Revue canadienne de sante publique · 2026Article
- "With this you're not chained down to something": contrasting experiences of opioid agonist treatment and safer supply program participation among people receiving prescribed safer supply.Harm reduction journal · 2026Article
- Expanding supervised consumption services in rural Canada: Bridging gaps.Canadian journal of public health = Revue canadienne de sante publique · 2025Article
- Exploring the Impact of Online Mental Health Resources During the COVID-19 Pandemic on Lesbian, Gay, Bisexual, Transgender, Queer, and Questioning Adults Compared to Heterosexual Adults: Pretest-Posttest Survey Analyses.JMIR formative research · 2025Article
- Defining terminology and outcome measures for evaluating overdose response technology: An international Delphi study.Drug and alcohol review · 2025Article
- Predictors of overdose response hotline use for mental health and fatal overdose prevention.Canadian journal of public health = Revue canadienne de sante publique · 2025Article
- Socioculturally Appropriate Internet-Based Geriatric Care Model for Older Adults Living With HIV: Experience-Based Co-Design Approach.JMIR aging · 2025Article
- "Oh, Another Overdose, for the Love of Pete": First Responder Perspectives on Overdose Response Technology.The western journal of emergency medicine · 2025Article
- Perceptions of overdose response hotlines and applications among rural and remote individuals who use drugs in Canada: a qualitative study.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2024Article
- Challenges of the COVID-19 pandemic on women's HIV harm reduction centers: a mixed-methods study.Harm reduction journal · 2024Article
- Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis.Harm reduction journal · 2024Article
- Accessibility gaps of physical supervised consumption sites in Canada motivating the use of overdose response technology/phone based virtual overdose response services: a retrospective cohort study.Lancet regional health. Americas · 2024Article
- Preference for hotline versus mobile application/countdown-based mobile overdose response services: a qualitative study.Harm reduction journal · 2024Article
- A cost benefit analysis of a virtual overdose monitoring service/mobile overdose response service: the national overdose response service.Substance abuse treatment, prevention, and policy · 2023Article
- Association of drug overdoses and user characteristics of Canada's national mobile/virtual overdose response hotline: the National Overdose Response Service (NORS).BMC public health · 2023Observational
- Feasibility and acceptability of inserts promoting virtual overdose monitoring services (VOMS) in naloxone kits: a qualitative study.Harm reduction journal · 2023Article
- Service-level barriers to and facilitators of accessibility to treatment for problematic alcohol use: a scoping review.Frontiers in public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic has increased the uptake of virtual and remote service delivery in the substance use field, which was previously uncommon. This swift uptake of virtual services provides an opportunity to improve service design to meet the diverse needs of women and gender-diverse people. Such services have the potential to better meet the needs of women and gender-diverse people by allowing for increased choice, control, and autonomy, enabling empowerment, facilitating greater considerations of power relations, violence, childcare responsibilities, and fostering greater inclusion of trans and non-binary people. This commentary aims to identify how virtual and remote delivery of substance use treatment and harm reduction services can be gender-responsive. We highlight the role gender transformative services play in meeting the unique needs of women and gender-diverse people who use drugs both during and after the COVID-19 pandemic. By using the unique window of opportunity COVID-19 has created to develop and deliver gender-transformative programs, we can help address the detrimental gaps in service accessibility and effectiveness that have persistently been experienced by women and gender-diverse people who use drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.